| 脑梗死生物标志物研究进展 |
| |
| 引用本文： | 潘晓晗,郝春华,陈芙蓉,王维亭,黄长江,汤立达. 脑梗死生物标志物研究进展[J]. 现代药物与临床, 2020, 35(1): 189-196 |
| |
| 作者姓名： | 潘晓晗 郝春华 陈芙蓉 王维亭 黄长江 汤立达 |
| |
| 作者单位： | 天津药物研究院, 天津 300301,天津药物研究院, 天津 300301,天津药物研究院, 天津 300301,天津药物研究院, 天津 300301,天津药物研究院, 天津 300301,天津药物研究院, 天津 300301 |
| |
| 基金项目： | 天津市科技支撑重点项目（19YFZCSY00620） |
| |
| 摘 要： | 脑梗死发病率高,死亡率高,因其病因复杂,治疗时间窗受限,诊断、治疗中存在一定程度的风险,因而寻找一种能简单、迅速、有效的用于诊断与治疗脑梗死的生物标志物,逐渐成为研究的热点。对近几年来研究的可能作为脑梗死诊断、治疗以及预后风险评估的生物标记物进行综述。
|
| 关 键 词： | 生物标记物 脑梗死 诊断 治疗 预后监测 |
| 收稿时间： | 2019-10-26 |
Research progress on biomarkers for cerebral infraction |
| |
| PAN Xiao-han,HAO Chun-hu,CHEN Fu-rong,WANG Wei-ting,HUANG Chang-jiang and TANG Li-da. Research progress on biomarkers for cerebral infraction[J]. Drugs & Clinic, 2020, 35(1): 189-196 |
| |
| Authors: | PAN Xiao-han HAO Chun-hu CHEN Fu-rong WANG Wei-ting HUANG Chang-jiang TANG Li-da |
| |
| Affiliation: | Tianjin Institute of Pharmaceutical Research, Tianjin 300301, China,Tianjin Institute of Pharmaceutical Research, Tianjin 300301, China,Tianjin Institute of Pharmaceutical Research, Tianjin 300301, China,Tianjin Institute of Pharmaceutical Research, Tianjin 300301, China,Tianjin Institute of Pharmaceutical Research, Tianjin 300301, China and Tianjin Institute of Pharmaceutical Research, Tianjin 300301, China |
| |
| Abstract: | Cerebral infraction had the high incidence and high mortality. Because cerebral infraction has complex etiology and treatment time window is limited, and there are certain risks in diagnosis and treatment, searching for a simple, rapid, and effective biomarker for the diagnosis and treatment of cerebral infarction has gradually become a focus of research. The recent studies on possible biomarkers for the diagnosis, treatment, and prognostic risk assessment of cerebral infarction are reviewed in this paper. |
| |
| Keywords: | biomarker cerebral infraction diagnosis treatment prognosis |
| 本文献已被 CNKI 等数据库收录！ |
| 点击此处可从《现代药物与临床》浏览原始摘要信息 |
|
点击此处可从《现代药物与临床》下载全文 |
|
